Get the Finder app 🥳

Track your credit score

Free

How to buy Immuron shares | A$0.26

Own Immuron shares in just a few minutes.

Posted

Fact checked

We’re committed to our readers and editorial independence. We don’t compare all products in the market and may receive compensation when we refer you to our partners, but this does not influence our opinions or reviews. Learn more about Finder.

Immuron Limited is a biotechnology business based in Australia. Immuron shares (IMC) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.26 – a decrease of 1.89% over the previous week. Immuron has a trailing 12-month revenue of around $2.5 million.

How to buy shares in Immuron

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Immuron . Find the share by name or ticker symbol: IMC. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Immuron reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price of $0.26, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Immuron . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Immuron 's share price?

Since the stock market crash in March caused by coronavirus, Immuron 's share price has had significant positive movement.

Its last market close was $0.26, which is 42.31% up on its pre-crash value of $0.15 and 420.00% up on the lowest point reached during the March crash when the shares fell as low as $0.05.

If you had bought $1,000 worth of Immuron shares at the start of February 2020, those shares would have been worth $630.77 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,000.00.

Immuron share price

Use our graph to track the performance of IMC stocks over time.

Immuron shares at a glance

Information last updated 2020-10-20.
Latest market closeAUDA$0.26
52-week rangeAUDA$0.07 - AUDA$0.95
50-day moving average AUDA$0.2753
200-day moving average AUDA$0.2371
Target priceAUDA$19.26
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) AUDA$-0.032

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

  • Brokerage - AU shares: From AUD 5 or 0.05%
  • Brokerage - US shares: USD 0
  • Sign-up process: Instant
  • Support - After hours: Yes
Go to site
More info

Important: Share trading carries risk of capital loss.

Promoted

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data indicated here is updated regularly
Name Product Standard brokerage fee Inactivity fee Markets
IG Share Trading
Finder Award
IG Share Trading
AUD 8 or 0.1%
AUD 50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares, Forex, CFDs, Margin trading
Brokerage discount: $5 on Australian shares for active traders & $0 commission on US and global shares
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, forex and CFDs, plus get access to 24-hour customer support.
Superhero share trading
AUD 5
No
ASX shares
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
CMC Markets Stockbroking
AUD 11 or 0.1%
No
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, mFunds
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, managed funds, forex, commodities and cryptocurrencies, plus access up to 15 major global and Australian stock exchanges.
ANZ Share Investing
AUD 19.95
No
ASX shares, Global shares, Margin trading, Options trading
Earn 1 Qantas Point per AU$3 spent on brokerage fees on certain instruments.
Access Morningstar reports, company announcements and and live pricing via ANZ’s share investing platform. Available for desktop and mobile.
Westpac Online Investing Account
AUD 19.95 or 0.11%
AUD 63.50 per year on the global markets account
ASX shares, Global shares, Options trading, US shares
loading

Compare up to 4 providers

Is it a good time to buy Immuron stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Immuron price performance over time

Historical closes compared with the close of A$0.26 on 2020-10-22

1 week (2020-10-23) -3.70%
1 month (2020-10-01) -1.89%
3 months (2020-07-31) -27.78%
6 months (2020-05-01) 173.68%
1 year (2019-10-31) 108.00%
2 years (2018-10-31) -3.70%
3 years (2017-10-31) 52.94%
5 years (2015-10-29) -46.47%

Immuron financials

Revenue TTM $2.5 million
Gross profit TTM $1.8 million
Return on assets TTM -24.7%
Return on equity TTM -45.05%
Profit margin -116.23%
Book value 0.032
Market capitalisation $57.4 million

TTM: trailing 12 months

Immuron share dividends

We're not expecting Immuron to pay a dividend over the next 12 months.

Have Immuron 's shares ever split?

Immuron 's shares were split on a 1:40 basis on 16 November 2014. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Immuron shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Immuron shares which in turn could have impacted Immuron 's share price.

Immuron share price volatility

Over the last 12 months, Immuron 's shares have ranged in value from as little as $0.07 up to $0.95. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Immuron 's is 2.5031. This would suggest that Immuron 's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Immuron overview

Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immune modulated diseases in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. The company markets Travelan and Protectyn for the prevention of travellers' diarrhea. Its lead product candidates include IMM-124E that is in Phase II clinical trials for non-alcoholic steatohepatitis, severe alcoholic hepatitis, and non-alcoholic fatty liver disease, as well as used in antiviral activity against the COVID-19 virus in laboratory studies; and IMM-529, a clinical stage product for clostridium difficile infections. Immuron Limited was founded in 1994 and is based in Blackburn North, Australia.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site